Skip to main content
. 2024 Jun 11;16(6):793. doi: 10.3390/pharmaceutics16060793

Figure 3.

Figure 3

(A) Scheme for creation and application of Ti-MOF-MO-aided LDI-MS, workflow diagram of examining urine metabolites. (B) RCCs sensor using metabolic fingerprinting and ML. Reproduced from ref. [49] with permission from American Chemical Society, copyright 2022.